glycylsarcosine has been researched along with indomethacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Kaku, T; Liu, K; Liu, Q; Meng, Q; Wang, C; Wang, W | 1 |
2 other study(ies) available for glycylsarcosine and indomethacin
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Effects of JBP485 on the expression and function of PEPT1 in indomethacin-induced intestinal injury in rats and damage in Caco-2 cells.
Topics: Animals; Blotting, Western; Caco-2 Cells; Chromatography, Liquid; Dipeptides; Humans; In Vitro Techniques; Indomethacin; Intestinal Mucosa; Intestines; Lipid Peroxidation; Male; Oxidative Stress; Peptide Transporter 1; Peptides, Cyclic; Peroxidase; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Symporters; Tandem Mass Spectrometry | 2011 |